1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $20.1 million of Shares

February 13, 2019 | About:

CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Jeffrey M Leiden sold 111,431 shares of VRTX on 02/11/2019 at an average price of $180.24 a share. The total sale was $20.1 million.

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO. Vertex Pharmaceuticals Inc has a market cap of $47.34 billion; its shares were traded at around $185.25 with a P/E ratio of 22.93 and P/S ratio of 16.93.

CEO Recent Trades:

  • CEO & President Jeffrey M Leiden sold 111,431 shares of VRTX stock on 02/11/2019 at the average price of $180.24. The price of the stock has increased by 2.78% since.
  • CEO & President Jeffrey M Leiden sold 32,250 shares of VRTX stock on 02/04/2019 at the average price of $186.35. The price of the stock has decreased by 0.59% since.

CFO Recent Trades:

  • SVP & Interim CFO Paul M Silva sold 4,215 shares of VRTX stock on 02/11/2019 at the average price of $180.16. The price of the stock has increased by 2.83% since.
  • SVP & Interim CFO Paul M Silva sold 1,289 shares of VRTX stock on 02/06/2019 at the average price of $193. The price of the stock has decreased by 4.02% since.
  • SVP & Interim CFO Paul M Silva sold 4,247 shares of VRTX stock on 02/04/2019 at the average price of $187.02. The price of the stock has decreased by 0.95% since.

Directors and Officers Recent Trades:

  • EVP, CRO Amit Sachdev sold 35,095 shares of VRTX stock on 02/11/2019 at the average price of $180.06. The price of the stock has increased by 2.88% since.
  • EVP\Chief Commercial Officer Stuart A Arbuckle sold 33,073 shares of VRTX stock on 02/11/2019 at the average price of $180.21. The price of the stock has increased by 2.8% since.
  • EVP, Global Research and CSO David Altshuler sold 32,956 shares of VRTX stock on 02/11/2019 at the average price of $180.22. The price of the stock has increased by 2.79% since.
  • EVP, CL&AO Michael Parini sold 12,136 shares of VRTX stock on 02/11/2019 at the average price of $180.22. The price of the stock has increased by 2.79% since.
  • EVP, CRO Amit Sachdev sold 12,722 shares of VRTX stock on 02/04/2019 at the average price of $186.86. The price of the stock has decreased by 0.86% since.

For the complete insider trading history of VRTX, click here

.

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


Stephen NeumeierGreenblatt Low Beta
ntelumRUSMIN ANG
DANGORDONOPER MARGIN OVER 20%
DBrizannoDiv19feb2019
jbucheliHighly Leveraged
jbostwickosv growth 50% gpa MidCAP Best
crmaasteste2
mgr1929Start%20screening%20here
pbarker46Start screening here
tnavasardianNA high yield
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK